HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 9 October 2014

Recently published CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. From the ones listed this time, here's a few in our areas of research interest:

Mihalopoulos C, Chen G, Iezzi A, et. al. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures. Br J Psychiatry. 2014 Sep 25. [Epub ahead of print] PubMed PMID: 25257063.

Bock JA, Fairley KJ, Smith RE, et. al. Cost-Effectiveness of IL28? Genotype-Guided Protease Inhibitor Triple Therapy versus Standard of Care Treatment in Patients with Hepatitis C Genotypes 2 or 3 Infection. Public Health Genomics. 2014 Sep 18. [Epub ahead of print] PubMed PMID: 25247313.

Negrón ME, Kaplan GG, Barkema HW, et. al. Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: An Economic Evaluation. Inflamm Bowel Dis. 2014 Sep 16. [Epub ahead of print] PubMed PMID: 25230162.

Laramée P, Brodtkorb TH, Rahhali N, et. al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open. 2014 Sep 16;4(9):e005376. PubMed PMID: 25227627.